Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical insulin for dry eye disease in patients using topical hypotensive drugs
2022-002434-13Phase 4Active
- Sponsor
- Barbara Burgos-Blasco
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in dry eye syndrome (DED) comparing Topical insulin with Placebo/artificial tears (2 arms). Primary endpoint: Change in OSDI questionnaire score. Started Aug 2022; status: active.
02
Drugs
human insulin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2022-002434-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-002434-13.